New drug combo may slash heart attack risk for patients with dangerous plaque
NCT ID NCT06863545
First seen Feb 06, 2026 · Last updated May 15, 2026 · Updated 13 times
Summary
This study tests whether adding a PCSK9 inhibitor (a powerful cholesterol-lowering drug) to standard treatment can reduce major heart problems like heart attacks, strokes, or death in people with high-risk plaque in their coronary arteries. About 3,600 adults with specific plaque features seen on a CT scan will be enrolled. The goal is to see if the extra medication helps control the disease better than standard care alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hangzhou Linping First People's Hospital
RECRUITINGHangzhou, China
Contact
-
Jinhua Central Hospital
RECRUITINGJinhua, China
Contact
-
Seoul National University Hospital
NOT_YET_RECRUITINGSeoul, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Second Affiliated Hospital, School of Medicine, Zhejiang University
RECRUITINGHangzhou, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Zhejiang Hospital
RECRUITINGHangzhou, China
Contact
-
Zhejiang Provincial Hospital of Traditional Chinese Medicine
RECRUITINGHangzhou, Zhejiang, China
Contact
Conditions
Explore the condition pages connected to this study.